Clinical Trial Update: Randomized Short-term Pre-surgical Study to Assess the Effects of Abemaciclib (LY2835219) in Early Breast Cancer Patients [Phase 2]

View source ↗

Summary

A Phase 2 randomized short-term pre-surgical study evaluating the effects of abemaciclib in patients with early breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• VERZENIO (ABEMACICLIB)

Snippet

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED